Baldwin Brothers »

Ligand Pharmaceuticals In shares owned by Baldwin Brothers

Quarter-by-quarter ownership of Ligand Pharmaceuticals In (LGND) shares owned by Baldwin Brothers from 13F filings

Historical chart of Baldwin Brothers investment in Ligand Pharmaceuticals In

Tip: Access up to 7 years of quarterly data

All positions including Ligand Pharmaceuticals In held by Baldwin Brothers consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Ligand Pharmaceuticals In by Baldwin Brothers

Quarter filed Position value Share count Share price at filing
2026-06-30 $288k 911 316.09
2024-09-30 $360k 3.6k 100.09

More positions owned by Baldwin Brothers

Alphabet Cap Stk Cl A (GOOGL)
Apple (AAPL)
NVIDIA Corporation (NVDA)
J P Morgan Exchange Traded F Active Bond Etf (JBND)
Amazon (AMZN)
Kla Corp Com New (KLAC)
Microsoft Corporation (MSFT)
Ishares Tr Tips Bd Etf (TIP)
Visa Com Cl A (V)
Spdr Gold Tr Gold Shs (GLD)
Asml Hldg Nv N Y Registry Shs (ASML)
Invesco Exch Trd Slf Idx Rusl 1000 Dynm (OMFL)
JPMorgan Chase & Co. (JPM)
United Rentals (URI)
Waste Management (WM)

View all positions for Baldwin Brothers

Top funds holding Ligand Pharmaceuticals In

BlackRock
Vanguard Portfolio Management
Henderson Group
Vanguard Capital Management
Invesco
State Street Corporation
Congress Asset Management
FMR
Nomura Asset Management International
Franklin Resources
Geode Capital Management
Chicago Capital
Stephens Investment Management Group
Dimensional Fund Advisors
Massachusetts Financial Services

View all funds holding Ligand Pharmaceuticals In